SELENON
Selenoprotein N
Also known as: MDRS1, RSMD1, RSS, SELN, SELN_HUMAN, SEPN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZV5
- Gene
- SELENON
- Ensembl
- ENSG00000162430
- Chromosome
- 1
- Canonical length
- 590 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a glycoprotein that is localized in the endoplasmic reticulum. It plays an important role in cell protection against oxidative stress, and in the regulation of redox-related calcium homeostasis. Mutations in this gene are associated with early onset muscle disorders, referred to as SEPN1-related myopathy. SEPN1-related myopathy consists of 4 autosomal recessive disorders, originally thought to be separate entities: rigid spine muscular dystrophy (RSMD1), the classical form of multiminicore disease, desmin related myopathy with Mallory-body like inclusions, and congenital fiber-type disproportion (CFTD). This protein is a selenoprotein, containing the rare amino acid selenocysteine (Sec). Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. A second stop-codon redefinition element (SRE) adjacent to the UGA codon has been identified in this gene (PMID:15791204). SRE is a phylogenetically conserved stem-loop structure that stimulates readthrough at the UGA codon, and augments the Sec insertion efficiency by SECIS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2016]
Canonical amino-acid sequenceUniProt
590 residues, UniProt reviewed canonical sequence.
>Q9NZV5|SELENON
1 MGRARPGQRG PPSPGPAAQP PAPPRRRARS LALLGALLAA AAAAAVRVCA RHAEAQAAAR
61 QELALKTLGT DGLFLFSSLD TDGDMYISPE EFKPIAEKLT GSCSVTQTGV QWCSHSSLQP
121 QLPWLNUSSC LSLLRSTPAA SCEEEELPPD PSEETLTIEA RFQPLLPETM TKSKDGFLGV
181 SRLALSGLRN WTAAASPSAV FATRHFQPFL PPPGQELGEP WWIIPSELSM FTGYLSNNRF
241 YPPPPKGKEV IIHRLLSMFH PRPFVKTRFA PQGAVACLTA ISDFYYTVMF RIHAEFQLSE
301 PPDFPFWFSP AQFTGHIILS KDATHVRDFR LFVPNHRSLN VDMEWLYGAS ESSNMEVDIG
361 YIPQMELEAT GPSVPSVILD EDGSMIDSHL PSGEPLQFVF EEIKWQQELS WEEAARRLEV
421 AMYPFKKVSY LPFTEAFDRA KAENKLVHSI LLWGALDDQS CUGSGRTLRE TVLESSPILT
481 LLNESFISTW SLVKELEELQ NNQENSSHQK LAGLHLEKYS FPVEMMICLP NGTVVHHINA
541 NYFLDITSVK PEEIESNLFS FSSTFEDPST ATYMQFLKEG LRRGLPLLQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SELENON can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 58 nTPM
- adipose tissue: 55 nTPM
- breast: 52 nTPM
- smooth muscle: 52 nTPM
- heart muscle: 49 nTPM
- pancreas: 49 nTPM
Single-cell type
- lymphatic endothelial cells: 15 nCPM
- adrenal medulla cells: 11 nCPM
- basal prostatic cells: 9.6 nCPM
- vascular endothelial cells: 9.4 nCPM
- epicardial cells: 9.1 nCPM
- salivary ionocytes: 8.7 nCPM
Immune cell
- basophil: 2.4 nTPM
- eosinophil: 1.5 nTPM
- classical monocyte: 0.9 nTPM
- non-classical monocyte: 0.8 nTPM
- intermediate monocyte: 0.7 nTPM
- naive CD4 T-cell: 0.7 nTPM
Brain region
- choroid plexus: 109 nTPM
- medulla oblongata: 109 nTPM
- thalamus: 87 nTPM
- midbrain: 71 nTPM
- spinal cord: 69 nTPM
- pons: 65 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SELENON.
Disease | AllUniProt
Conditions SELENON is implicated in, by any mechanism.
- Congenital myopathy 3 with rigid spine (CMYO3) MIM:602771
Disease | GeneticClinVar
114 pathogenic / likely-pathogenic of 816 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Eichsfeld type congenital muscular dystrophy
- Congenital myopathy with fiber type disproportion
- Congenital myopathy 4A, autosomal dominant
- SEPN1-related disorder
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ATP metabolic process
- calcium ion homeostasis
- calcium ion import
- cell redox homeostasis
- cellular response to caffeine
- cellular response to oxidative stress
- collagen fibril organization
- diaphragm contraction
- energy reserve metabolic process
- gene expression
- L-ascorbic acid metabolic process
- L-ascorbic acid transmembrane transport
- lung alveolus development
- membrane biogenesis
- membrane organization
- membrane to membrane docking
- mitochondrial calcium ion transmembrane transport
- mitochondrion organization
- mitochondrion-endoplasmic reticulum membrane tethering
- multicellular organismal response to stress
- positive regulation of response to oxidative stress
- positive regulation of skeletal muscle cell proliferation
- regulation of ryanodine-sensitive calcium-release channel activity
- response to endoplasmic reticulum stress
- response to muscle activity involved in regulation of muscle adaptation
- skeletal muscle fiber development
- skeletal muscle satellite cell differentiation
- skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
- transforming growth factor beta receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SELENON in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SELENON as an antibody target. Whether an autoantibody or antibody against SELENON could matter depends on whether native SELENON is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SELENON is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SELENON as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...